Recruiting

Genetic Analysis

Sponsor:

Rutgers, The State University of New Jersey

Code:

NCT07714044

Conditions

Blood Cancers

Blood Cancer

Leukemia

Lymphoma

Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.

Conditions

Blood Cancers

Blood Cancer

Leukemia

Lymphoma

Myeloma

Study ID

NCT07714044

Start date

Sep 22, 2026

Status verified date

Sep, 2026

Completion date

Aug, 2029

Anticipated

Primary completion date

Aug, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • age 18 years or older
  • currently living in the United States
  • have access to the internet and a computer, laptop, tablet or smartphone
  • willing to provide written informed consent for participation
  • willing to provide DNA via a saliva sample using a collection kit mailed to your home
  • willing to complete a survey with questions about health related to the study of blood cancer.

Exclusion Criteria:

  • Not able to meet or fulfill any of the inclusion criteria

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Arms

Cases

Persons with blood cancer

Controls

Persons who do not have blood cancer

Primary outcome measure

  • Genetic risk variants associated with blood cancer [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

Tara Matise, PhD

848-445-3125rugcc@rutgers.edu

Locations

Rutgers University

Recruiting

Piscataway, New Jersey, United States, 08854

Contacts

Tara Matise, PhD

848-445-3125rugcc@rutgers.edu

Principal Investigator:

Tara Matise, PhD

More Information

Sponsor

Rutgers, The State University of New Jersey

Last update posted

Sep 23, 2026

Last verified

Sep, 2026

Keywords

  • genetics
  • blood cancer
  • blood cancers
  • leukemia
  • lymphoma
  • myeloma
  • hematologic cancer
  • hematologic malignancy
  • hematologic tumor
  • hematologic neoplasm

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-24. This information was provided to ClinicalTrials.gov by Rutgers, The State University of New Jersey on 2026-09-23. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.